Mini-Crush or Controlled Balloon-Crush for True Coronary Bifurcation Lesions
Launched by ISTANBUL MEHMET AKIF ERSOY EDUCATIONAL AND TRAINING HOSPITAL · Mar 17, 2025
Trial Information
Current as of April 30, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two techniques, known as mini-crush and controlled balloon-crush, for treating complex heart conditions called coronary bifurcation lesions. These lesions occur where a coronary artery branches into two smaller arteries, and the goal is to improve blood flow to the heart while minimizing complications like heart attacks or strokes. The trial compares how well these two methods work in patients with specific types of bifurcation lesions, focusing on how safely and effectively they can be performed.
To be eligible for this trial, participants must be over 18 years old and have a complex coronary bifurcation lesion. Some individuals may not qualify if they have certain conditions, such as simpler bifurcation anatomy or serious health issues like advanced liver or kidney disease. Those who join the study can expect to undergo a procedure using one of the stenting techniques and will be monitored for one year to see how well they recover and if there are any complications. It's important to know that this research aims to improve treatment options for patients with these challenging heart conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged \>18
- • PCI with mini-crush or controlled balloon-crush
- • Complex coronary bifurcation lesion (Medina 0.1.1 and Medina 1.1.1)
- Exclusion Criteria:
- • Non-complex bifurcation anatomy
- • Bail-out 2-stent (reverse mini-crush or reverse controlled balloon-crush)
- • ST-elevation myocardial infarction
- • Cardiogenic shock status
- • In-stent restenosis
- • A history of coronary artery bypass grafting
- • Implantation of bare-metal stent
- • End-stage hepatic or renal disease
- • \<1-year life expectancy
About Istanbul Mehmet Akif Ersoy Educational And Training Hospital
Istanbul Mehmet Akif Ersoy Educational and Training Hospital is a leading healthcare institution dedicated to advancing medical research and education. As a prominent clinical trial sponsor, the hospital is committed to enhancing patient care through innovative studies that focus on developing new treatments and therapies. With a strong emphasis on ethical standards and patient safety, the hospital collaborates with a diverse team of healthcare professionals and researchers to foster advancements in clinical knowledge and practice. Its state-of-the-art facilities and comprehensive training programs position it as a key contributor to the medical community in Turkey and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İstanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported